NCT00385606 2023-03-23
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
National Cancer Institute, Naples
Phase 2/3 Completed
Clinical Trials
4 trialsNCT00060476 2017-05-09
Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00031863 2013-08-02
Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00637988 2011-01-21
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca
Phase 4 Completed